Literature DB >> 15126006

Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients.

Jiazhong Sun1, Yancheng Xu, Yilian Zhu, Hongyun Lu.   

Abstract

OBJECTIVE: Genetic predisposition has been implicated in diabetic nephropathy (DN). The C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene, one of the key enzymes catalyzing remethylation of homocysteine, may play a role in the development of not only vascular disease but also diabetic microangiopathies. In this study, we examined the distribution of the MTHFR genotypes in the Chinese population and the association between the C677T variant and diabetic nephropathy.
METHODS: 220 unrelated patients with type 2 diabetes mellitus and 130 controls were recruited. The MTHFR genotype was analyzed by PCR followed by HinfI digestion. Plasma total homocysteine levels were measured using high-performance liquid chromatography (HPLC) with fluorescence detection.
RESULTS: In 130 healthy control subjects, the frequency of the mutant T allele was 30.0%, comparable to that of a Hong Kong (Chinese) population. The distribution of the three genotypes was as follows: TT genotype, 16.9%; CT genotype, 26.2%; and CC genotype, 56.9%. This genotype distribution did not differ between control subjects and type 2 diabetic patients in which 19.1% were TT, 34.5% were CT and 46.4% were CC (2=3.85, P>0.05). The frequency of the mutant T allele was 42.3% in diabetic patients with nephropathy (n=124) versus 28.6% in those without nephropathy (n=96). The genotype frequencies were TT, 21.0%; CT, 42.7%; CC, 36.3% in diabetic patients with nephropathy versus TT, 16.7%; CT, 23.9%; CC, 59.4% in those without nephropathy. The MTHFR genotype and allele frequencies were different between diabetic patients with and without nephropathy (chi2=12.27, P<0.005; chi2=8.77, P<0.005, respectively). Moreover, plasma homocysteine levels were markedly higher in individuals with TT genotype than those with CC or CT genotype.
CONCLUSIONS: The C677T mutation of MTHFR gene is common in the Chinese population. MTHFR C677T gene polymorphism associated with a predisposition to increased plasma homocysteine levels may represent a genetic risk factor for diabetic nephropathy in Chinese type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126006     DOI: 10.1016/j.diabres.2003.10.022

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  16 in total

1.  Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.

Authors:  Mohammad Reza Safarinejad; Nayyer Shafiei; Shiva Safarinejad
Journal:  Med Oncol       Date:  2010-10-29       Impact factor: 3.064

2.  Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis.

Authors:  Elias Zintzaras; Katrin Uhlig; George N Koukoulis; Afroditi A Papathanasiou; Ioannis Stefanidis
Journal:  J Hum Genet       Date:  2007-09-06       Impact factor: 3.172

3.  MTHFR gene C677T polymorphism and type 2 diabetic nephropathy in Asian populations: a meta-analysis.

Authors:  Haiyan Chen; Fang Wei; Lihua Wang; Zhe Wang; Jia Meng; Lan Jia; Guijiang Sun; Ruining Zhang; Bo Li; Haibo Yu; Haiyan Pang; Xueqing Bi; Hongye Dong; Aili Jiang; Lin Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  The genetics of vascular complications in diabetes mellitus.

Authors:  Dan Farbstein; Andrew P Levy
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

5.  Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).

Authors:  Maple M Fung; Rany M Salem; Michael S Lipkowitz; Vibha Bhatnagar; Braj Pandey; Nicholas J Schork; Daniel T O'Connor
Journal:  Nephrol Dial Transplant       Date:  2011-05-25       Impact factor: 5.992

6.  The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis.

Authors:  Elias Zintzaras; Dimitrios Z Chatzoulis; Costas H Karabatsas; Ioannis Stefanidis
Journal:  J Hum Genet       Date:  2005-05-18       Impact factor: 3.172

7.  MTHFR A1298C polymorphism is associated with cardiovascular risk in end stage renal disease in North Indians.

Authors:  Aruna Poduri; Debabrata Mukherjee; Kamal Sud; Harbir Singh Kohli; Vinay Sakhuja; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2007-09-25       Impact factor: 3.396

8.  MTHFR (Ala 222 Val) polymorphism and AMI in patients with type II diabetes mellitus.

Authors:  T Angeline; G Thiruvarutselvi; W Isabel; Rita Mary Aruna; Rama Devi; Nirmala Jeyaraj
Journal:  Indian J Clin Biochem       Date:  2009-07-09

Review 9.  ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy.

Authors:  Zohreh Rahimi
Journal:  J Nephropathol       Date:  2012-10-01

10.  Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study.

Authors:  Franziska Marti; Peter Vollenweider; Pedro-Manuel Marques-Vidal; Vincent Mooser; Gérard Waeber; Fred Paccaud; Murielle Bochud
Journal:  BMC Public Health       Date:  2011-09-26       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.